TGFB1 and acute myeloid leukemia: Regarding transformation into secondary AML, moderate/strong TGF-β1 staining was observed more frequently in patients who developed secondary AML (27.8%) compared to those with weak/no staining (13.2%), but this difference was not statistically significant (P ═ 0.263).